FIELD: medicine.
SUBSTANCE: invention refers to biotechnology and genetic engineering. A cell contains a construct, which comprises a sequence coding siRNA to a conserved region of a foot-and-mouth disease virus (FMDV) or avian influenza virus. What is disclosed is producing a transgenic vertebrate, other than a human from the above cells, which possess the resistance to the above viral diseases. The invention can be used in animal production and veterinary science.
EFFECT: what is presented is a transgenic embryo cell of a vertebrate, other than a human.
22 cl, 20 dwg, 4 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| RECOMBINANT HVT-VECTORS EXPRESSING MULTIPLE ANTIGENS OF AVIAN PATHOGENS AND VACCINES CONTAINING THESE VECTORS | 2017 |
|
RU2752836C2 |
| MULTIVALENT RECOMBINANT AVIAN HERPES VIRUSES AND VACCINES FOR IMMUNISING AVIAN SPECIES | 2013 |
|
RU2658439C2 |
| RECOMBINANT HVT VECTORS EXPRESSING BIRD PATHOGENS ANTIGENS AND THEIR APPLICATION | 2012 |
|
RU2620936C2 |
| RECOMBINANT MAREK'S DISEASE VIRUSES AND USES THEREOF | 2014 |
|
RU2681889C2 |
| RECOMBINANT NEWCASTLE DISEASE VIRUS EXPRESSING H5 HEMAGGLUTININ OF AVIAN INFLUENZA VIRUS | 2007 |
|
RU2441070C2 |
| FMDV-E2 FUSION PROTEINS AND USE THEREOF | 2016 |
|
RU2714428C2 |
| POLYPEPTIDES AND POLYNUCLEOTIDES AND THEIR USE FOR TREATMENT OF IMMUNE DISORDERS AND CANCER | 2012 |
|
RU2623161C2 |
| RECOMBINANT VIRUSES MDV1 AND APPLICATION THEREOF | 2016 |
|
RU2714423C2 |
| FMDV VACCINES BASED ON A RECOMBINANT ADENOVIRAL VECTOR AND USE THEREOF | 2017 |
|
RU2725495C2 |
| MULTIVALENT RECOMBINANT AVIAN HERPES VIRUSES AND VACCINES FOR IMMUNISATION OF BIRDS | 2013 |
|
RU2766003C2 |
